Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
Open Access
- 8 March 2010
- journal article
- research article
- Published by Springer Science and Business Media LLC in BMC Infectious Diseases
- Vol. 10 (1), 57-9
- https://doi.org/10.1186/1471-2334-10-57
Abstract
BACKGROUND: Interferon-gamma (IFN-γ) Release Assays (IGRA) are more specific than the tuberculosis skin test (TST) in the diagnosis of latent tuberculosis (TB) infection (LTBI). We present the performance of the QuantiFERON®-TB Gold In-tube (QFT-TB) assay as diagnostic test and during follow-up of preventive TB therapy in outpatients from a TB low-endemic country. METHODS: 481 persons with suspected TB infection were tested with QFT-TB. Thoracic X-ray and sputum samples were performed and a questionnaire concerning risk factors for TB was filled. Three months of isoniazid and rifampicin were given to patients with LTBI and QFT-TB tests were performed after three and 15 months. RESULTS: The QFT-TB test was positive in 30.8% (148/481) of the total, in 66.9% (111/166) of persons with origin from a TB endemic country, in 71.4% (20/28) previously treated for TB and in 100% (15/15) of those diagnosed with active TB with no inconclusive results. The QFT-TB test was more frequently positive in those with TST ≥ 15 mm (47.5%) compared to TST 11-14 mm (21.3%) and TST 6-10 mm (10.5%), (p 0.05). CONCLUSION: Only one third of those with suspected TB infection had a positive QFT-TB test. Recent immigration from TB endemic countries and long duration of exposure are risk factors for a positive QFT-TB test and these groups should be targeted through screening. Since most patients remained QFT-TB positive after therapy, the test should not be used to monitor the effect of preventive therapy. Prospective studies are needed in order to determine the usefulness of IGRA tests during therapy.Keywords
This publication has 55 references indexed in Scilit:
- Use of interferon gamma-based assay to diagnose tuberculosis infection in health care workers after short term exposureBMC Infectious Diseases, 2009
- LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statementEuropean Respiratory Journal, 2009
- Evaluation of the Effect of Treatment of Latent Tuberculosis Infection on QuantiFERON-TB Gold Assay ResultsInfection Control & Hospital Epidemiology, 2009
- T-SPOT.TBresponses during treatment of pulmonary tuberculosisBMC Infectious Diseases, 2009
- Screening for tuberculosis infection among newly arrived asylum seekers: Comparison of QuantiFERON®TB Gold with tuberculin skin testBMC Infectious Diseases, 2008
- T-Cell Assays for Tuberculosis Infection: Deriving Cut-Offs for Conversions Using Reproducibility DataPLOS ONE, 2008
- Reproducibility of QuantiFERON-TB Gold In-Tube AssayClinical and Vaccine Immunology, 2008
- Discrepancy between Mycobacterium tuberculosis -Specific Gamma Interferon Release Assays Using Short and Prolonged In Vitro IncubationClinical and Vaccine Immunology, 2007
- Sensitivity of a Whole-Blood Interferon-Gamma Assay Among Patients with Pulmonary Tuberculosis and Variations in T-Cell Responses During Anti-Tuberculosis TreatmentInfection, 2007
- Serial Testing of Health Care Workers for Tuberculosis Using Interferon-γ AssayAmerican Journal of Respiratory and Critical Care Medicine, 2006